Search Ontology:
ChEBI
beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-L-Fucp
- Term ID
- CHEBI:147072
- Synonyms
-
- beta-D-galacto-hexopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->3)-6-deoxy-beta-L-galacto-hexopyranose
- beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-6-deoxy-beta-L-galactopyranose
- beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-L-fucopyranose
- Gal(b1-4)GlcNAc(b1-3)b-Fuc
- N-[(2S,3R,4R,5S,6R)-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(2S,3S,4R,5R,6S)-2,3,5-trihydroxy-6-methyloxan-4-yl]oxyoxan-3-yl]acetamide
- Definition
- An amino trisaccharide consisting of β-D-galactopyranose, 2-acetamido-2-deoxy-β-D-glucopyranose and β-L-fucopyranose joined in sequence by (1→4) and (1→3) glycosidic bonds.
- References
-
- glygen:G10016UC
- glytoucan:G10016UC
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-L-Fucp
Phenotype where environments contain beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-L-Fucp
Phenotype modified by environments containing beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-L-Fucp
Phenotype affecting beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-L-Fucp
Human Disease Model